Cocrystal Pharma Inc. (COCP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cocrystal Pharma Inc.

    NASDAQ: COCP · Real-Time Price · USD
    1.47
    0.01 (0.63%)
    At close: Sep 05, 2025, 3:59 PM
    1.42
    -3.40%
    Pre-market: Sep 08, 2025, 08:16 AM EDT

    Cocrystal Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 9.86M 26.35M 37.14M 58.7M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 29K 46K 46K 46K
    Receivables
    		 1.22M 890K 716K n/a
    Inventory
    		 n/a n/a 75K n/a
    Other Current Assets
    		 505K 1.85M 2.32M 50K
    Total Current Assets
    		 11.58M 29.09M 40.18M 59.32M
    Property-Plant & Equipment
    		 1.85M 2.12M 616K 931K
    Goodwill & Intangibles
    		 n/a n/a n/a 19.09M
    Total Long-Term Assets
    		 1.88M 2.17M 662K 20.07M
    Total Assets
    		 13.46M 31.26M 40.84M 79.39M
    Account Payables
    		 1.54M 1.22M 614K 578K
    Deferred Revenue
    		 n/a n/a n/a 719K
    Short-Term Debt
    		 n/a n/a 240K 236K
    Other Current Liabilities
    		 n/a 1.69M -8K -120K
    Total Current Liabilities
    		 2.43M 3.26M 1.22M 1.54M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 1.5M 1.61M 57K 298K
    Total Liabilities
    		 3.93M 4.88M 1.27M 1.84M
    Total Debt
    		 1.81M 1.85M 297K 534K
    Common Stock
    		 10K 10K 8K 98K
    Retained Earnings
    		 -333.42M -315.91M -297.93M -259.09M
    Comprehensive Income
    		 n/a n/a 0.00 n/a
    Shareholders Equity
    		 9.52M 26.38M 39.57M 77.55M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist